All lobbying filings

FEROX STRATEGIES

Lobbying for VIATRIS INC · Pharmaceutical company

Filing 4th Quarter - Report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 20, 2026

Income

$70,000.00

What the client paid this registrant for the period.

Client based in

Pennsylvania

Official filing document

Government bodies contacted 6

Commerce, Dept of (DOC)
Executive Office of the President (EOP)
Health & Human Services, Dept of (HHS)
HOUSE OF REPRESENTATIVES
SENATE
U.S. Trade Representative (USTR)

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 1

S 1071
National Defense Authorization Act for Fiscal Year 2026

Lobbying activity 2

Trade (domestic/foreign)

Trade issues related to generic medicines.

Pharmacy

Policy and oversight related to the generic pharmaceutical industry. Issues related to drug pricing. Issues related to FDA generic drug approval process. General issues related to Agriculture Appropriations and National Defense Authorization Act (S. 1071).

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.